Combined Effects of 2-Methoxyestradiol (Hypoxia-Inducible Factor 1<i>α</i> Inhibitor) and Dasatinib (A Second-Generation Tyrosine Kinase Inhibitor) on Chronic Myelocytic Leukemia Cells

<div>Cell survival rate and inhibition rate of K-562 cells treated with 2-ME2 for 24 h.</div>

Journal of Immunology Research

fig3

Figure 3

Figure 3: Combined Effects of 2-Methoxyestradiol (Hypoxia-Inducible Factor 1<i>α</i> Inhibitor) and Dasatinib (A Second-Generation Tyrosine Kinase Inhibitor) on Chronic Myelocytic Leukemia Cells 

Figure 3 | Combined Effects of 2-Methoxyestradiol (Hypoxia-Inducible Factor 1α Inhibitor) and Dasatinib (A Second-Generation Tyrosine Kinase Inhibitor) on Chronic Myelocytic Leukemia Cells 